Huaizhong Health Group, Inc.
ADAD
$0.00
$0.000.00%
OTC PK
| 01/31/2023 | 10/31/2022 | 07/31/2022 | 04/30/2022 | 01/31/2022 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 2.73% | -5.50% | -34.33% | -51.57% | -30.07% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 2.73% | -5.50% | -34.33% | -51.57% | -30.07% |
| Operating Income | -2.73% | 5.50% | 34.33% | 51.57% | 30.07% |
| Income Before Tax | -2.73% | 5.50% | 34.33% | 51.87% | 30.90% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -2.73% | 5.50% | 34.33% | 51.87% | 30.90% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -2.73% | 5.50% | 34.33% | 51.87% | 30.90% |
| EBIT | -2.73% | 5.50% | 34.33% | 51.57% | 30.07% |
| EBITDA | -- | -- | -- | -- | -- |
| EPS Basic | 0.00% | 10.00% | 38.46% | 84.44% | 94.58% |
| Normalized Basic EPS | 16.67% | 16.67% | 37.50% | 82.14% | 94.23% |
| EPS Diluted | 0.00% | 10.00% | 38.46% | 84.44% | 94.58% |
| Normalized Diluted EPS | 16.67% | 16.67% | 37.50% | 82.14% | 94.23% |
| Average Basic Shares Outstanding | 0.00% | 0.00% | -0.38% | 28.24% | 87.30% |
| Average Diluted Shares Outstanding | 0.00% | 0.00% | -0.38% | 28.24% | 87.30% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |